Prevention and Management of Toxicity in Organs at Risk (OAR) in a Community Setting

This activity focuses entirely on issues related to the Organs at Risk (OAR) in the setting of thoracic radiation. Discussion centers on protecting the OARs and managing acute and late toxicities. Each speaker focuses on a different clinical situation.

Implementation of a Prostate SBRT Program in the Community Setting

Conventionally fractionated external beam radiation therapy (EBRT) has a long-standing track record of safety and excellent treatment outcomes in the management of all prostate cancer risk groups.

Management of Unfavorable Intermediate-Risk Prostate Cancer: Role of SBRT, Brachytherapy and Androgen Deprivation

Unfavorable intermediate-risk prostate cancer is commonly encountered in clinical practice but there is relatively little data focusing on treatment outcomes specific and limited to this patient cohort, with most clinical trials grouping these patients with favorable intermediate-risk disease or

ASTRO/JASTRO Joint Session: Advances in Liver Cancer Radiation Therapy

The role of this activity reviews growing indications for radiation therapy for liver cancer, educates providers on radiation therapy options (SBRT, particle therapy) and the potential impact of hepatic reserve capacity on decision making, explores challenges and opportunities for clinical trials

Red Journal Oncology Scans - 2024

The field of cancer is a rapidly evolving field with new treatment approaches moving to clinic on a daily basis. Radiation Oncology is no different. It is extremely difficult for a practicing clinician to stay abreast of new developments in cancer care.

Implementation of a Prostate SBRT Program in the Community Setting (PRO 08)

Conventionally fractionated external beam radiation therapy (EBRT) has a long-standing track record of safety and excellent treatment outcomes in the management of all prostate cancer risk groups.

Pitfalls, Perils and Pearls: Identifying and Managing Gynecologic Treatment Toxicity

The introduction of novel therapies for gynecologic malignancies such as immunotherapy, SBRT and complex brachytherapy can lead to increased frequency of severe toxicities for which treatment options may be limited.

Practical Radiation Oncology Program 2024

This program is designed to address the needs of a community practice physician and includes disease site reviews, interactive case-based discussions, a business fundamentals review and a radiopharmaceuticals overview.

Bringing Rationalism to Empiricism: A Discussion on Empiric SBRT for Early-Stage Lung Cancer

Lung cancer screening is resulting in a higher incidence of early-stage lung cancer diagnoses. This commonly occurs among older patients with chronic lung disease who are at high risk for complications with attaining pathologic confirmation.

Evolving Therapeutic Strategies in the Multidisciplinary Management of Patients with Hepatocellular Carcinoma – Improving Outcomes

The management of Hepatocellular Carcinoma (HCC) should be conducted in a multidisciplinary setting to offer individualized therapy. Most patients with HCC are not candidates for curative treatments because of tumor extent or underlying liver dysfunction.

Pages

Subscribe to RSS - SBRT